CM
Capula Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.8M | Buy |
115,391
+34,670
| +43% | +$840K | 0.03% | 47 |
|
|
2025
Q1 | $2.05M | Buy |
80,721
+67,650
| +518% | +$1.71M | 0.01% | 93 |
|
|
2024
Q4 | $347K | Buy |
+13,071
| New | +$347K | ﹤0.01% | 119 |
|
|
2024
Q3 | – | Sell |
-31,931
| Closed | -$893K | – | 405 |
|
|
2024
Q2 | $893K | Sell |
31,931
-967
| -3% | -$27.1K | 0.01% | 88 |
|
|
2024
Q1 | $913K | Buy |
+32,898
| New | +$913K | 0.02% | 81 |
|
|
2023
Q4 | – | Sell |
-10,594
| Closed | -$351K | – | 371 |
|
|
2023
Q3 | $351K | Buy |
+10,594
| New | +$351K | 0.01% | 240 |
|
|
2023
Q2 | – | Sell |
-86,963
| Closed | -$3.55M | – | 437 |
|
|
2023
Q1 | $3.55M | Buy |
+86,963
| New | +$3.55M | 0.04% | 38 |
|
|
2022
Q4 | – | Sell |
-8,827
| Closed | -$386K | – | 545 |
|
|
2022
Q3 | $386K | Buy |
+8,827
| New | +$386K | 0.01% | 220 |
|
|
2022
Q2 | – | Sell |
-220
| Closed | -$11K | – | 138 |
|
|
2022
Q1 | $11K | Buy |
+220
| New | +$11K | ﹤0.01% | 52 |
|
|
2021
Q4 | – | Sell |
-32,876
| Closed | -$1.41M | – | 361 |
|
|
2021
Q3 | $1.41M | Sell |
32,876
-22,785
| -41% | -$980K | 0.02% | 174 |
|
|
2021
Q2 | $2.16M | Buy |
55,661
+44,593
| +403% | +$1.73M | 0.03% | 48 |
|
|
2021
Q1 | $401K | Buy |
+11,068
| New | +$401K | 0.01% | 96 |
|
|
2020
Q3 | – | Sell |
-304,950
| Closed | -$9.97M | – | 119 |
|
|
2020
Q2 | $9.97M | Buy |
304,950
+163,067
| +115% | +$5.33M | 0.35% | 5 |
|
|
2020
Q1 | $4.63M | Buy |
+141,883
| New | +$4.63M | 0.17% | 39 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 166 |
|